Bruce Campbell (2) Verano Holdings VRNO-CSE PAST TOP PICK Nov 21, 2022

Cannabis in the US. Expansion plans. Cheaper valuation than peers. Valuation should expand after tax-loss selling. Catalysts include acquisitions, diversification, legislative change. No dividend. (Analysts’ price target is $38.85)

(A Top Pick Dec 30/21, Down 55%) Cannabis sector and tax-loss selloff. Still thinks it's a fantastic opportunity. Loves the company. 50% discount to peers. One of the top 5 MSOs. Great revenue and earnings growth. US cannabis is cheap and growing.

It is in the Cannabis space in 13 states in the U.S. with 120 retail outlets. It went public at the top of the market and is now at half the valuation compared to its peers. It is cashed up with good profitability. There are a number of catalysts with more states considering legalization. Holds it in the Cannabis portfolio and will probably add more. Buy 11, Hold 0, Sell 0 (Analysts’ price target is $31.57)

(A Top Pick Jul 04/22, Down 9%)

Long-term business with a lot of catalysts, as shown in last couple of weeks with US legislation. Continues to grow, so cashflow will let them pay down debt.